ABSTRACT
Clinically relevant postoperative pancreatic fistula (CR-POPF) can significantly affect the treatment course and outcome in pancreatic cancer patients. Preoperative prediction of CR-POPF can aid the surgical decision-making process and lead to better perioperative management of patients. In this retrospective study of 108 pancreatic head resection patients, we present risk models for the prediction of CR-POPF that use combinations of preoperative computed tomography (CT)-based radiomic features, mesh-based volumes of annotated intra- and peripancreatic structures and preoperative clinical data. The risk signatures were evaluated and analysed in detail by visualising feature expression maps and by comparing significant features to the established CR-POPF risk measures. Out of the risk models that were developed in this study, the combined radiomic and clinical signature performed best with an average area under receiver operating characteristic curve (AUC) of 0.86 and a balanced accuracy score of 0.76 on validation data. The following pre-operative features showed significant correlation with outcome in this signature (p<0.05)- texture and morphology of the healthy pancreatic segment, intensity volume histogram-based feature of the pancreatic duct segment, morphology of the combined segment, and BMI. The predictions of this pre-operative signature showed strong correlation (Spearman correlation co-efficient, ρ = 0.7) with the intraoperative updated alternative fistula risk score (ua-FRS), which is the clinical gold standard for intraoperative CR-POPF risk stratification. These results indicate that the proposed combined radiomic and clinical signature developed solely based on preoperatively available clinical and routine imaging data can perform on par with the current state-of-the-art intraoperative models for CR-POPF risk stratification.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research was carried out within the Surgomics project funded by the German Federal Ministry of Health, University Hospital Heidelberg and Uniklinikum Carl Gustav Carus, Dresden. Partners from industry: Karl Storz GmbH and Phellow Seven GmbH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the retrospective analyses of clinical and imaging data was obtained from the Ethics Committee at the Technical University Dresden (BO-EK-263062020). All analyses were carried out in accordance with the relevant guidelines and regulations, in particular the Declaration of Helsinki and its later amendments. The local institutional review board (Ethics Committee at the Technical University Dresden) approved the study protocol (BO-EK-263062020) and waived written patient consent for the retrospective analysis of routinely acquired anonymised clinical data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* nithya.bhasker{at}nct-dresden.de; fiona.kolbinger{at}uniklinikum-dresden.de; jens-peter.kuehn{at}uniklinikum-dresden.de
↵++ shared last authorship
Subsetting/Selection of patients based on surgical procedure, Inclusion of comparison with the ua-FRS as intraoperative gold standard for risk stratification, Revision of all manuscript sections to improve clarity and readability
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
